Product Information

PROCHLORPERAZINE 5 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1057 per EA under NDC 60219203801. Its NADAC has been published 168 times since Sep 6, 2023.

FDA first approved this application on Apr 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PROCHLORPERAZINE 5 MG TABLET

prochlorperazine maleate
$0.1057per EA

Strength

5 mg/1

NDC

60219203801

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PROCHLORPERAZINE MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216598

FDA Approved

4/17/2023

TE Code

AB

On Market Since

4/21/2023

Pharmacological Classes

Phenothiazine
Phenothiazines

Price Statistics

The NADAC for PROCHLORPERAZINE 5 MG TABLET has been published 168 times since Sep 6, 2023, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1057 per EA
All-time high$0.2933 (Sep 13, 2023)
All-time low$0.1057 (Nov 18, 2026)
52-week high$0.1478
52-week low$0.1057
Median price$0.1525
Average price$0.1691
Largest weekly change+71.7% (Aug 21, 2024)
Weeks tracked168
Tracking sinceSep 6, 2023

Price History

1W

-5.2%

1M

-7.9%

3M

-10.3%

6M

-8.9%

1Y

-28.5%

3Y

-55.6%

5Y

N/A

All

-64.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the prochlorperazine maleate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PROCHLORPERAZINE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 5 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1057 per EA (NDC 60219203801), effective Nov 18, 2026.

How has the price of PROCHLORPERAZINE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for PROCHLORPERAZINE 5 MG TABLET has declined 64.0%. It has been tracked across 168 weekly CMS publications since Sep 6, 2023.

What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 5 MG TABLET?

Since Sep 6, 2023, the NADAC for PROCHLORPERAZINE 5 MG TABLET has ranged from a low of $0.1057 (Nov 18, 2026) to a high of $0.2933 (Sep 13, 2023), with a median of $0.1525 per EA.

Are there cheaper alternatives to PROCHLORPERAZINE 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PROCHLORPERAZINE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PROCHLORPERAZINE 5 MG TABLET?

PROCHLORPERAZINE 5 MG TABLET (NDC 60219203801) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.